These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 23938375

  • 1. MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.
    Nelson GS, Pink A, Lee S, Han G, Morris D, Ogilvie T, Duggan MA, Köbel M.
    Gynecol Oncol; 2013 Nov; 131(2):309-14. PubMed ID: 23938375
    [Abstract] [Full Text] [Related]

  • 2. Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.
    Ruiz I, Martín-Arruti M, Lopez-Lopez E, Garcia-Orad A.
    Gynecol Oncol; 2014 Jul; 134(1):20-3. PubMed ID: 24814467
    [Abstract] [Full Text] [Related]

  • 3. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA.
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.
    Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O'Malley DM, Cohn DE.
    Gynecol Oncol; 2009 Sep; 114(3):486-90. PubMed ID: 19515405
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
    Clay MR, Allison KH, Folkins AK, Longacre TA.
    Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
    [Abstract] [Full Text] [Related]

  • 7. [Lynch syndrome-related endometrial carcinoma].
    Pang SJ, Guo DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):494-7. PubMed ID: 22932468
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High homogeneity of MMR deficiency in ovarian cancer.
    Fraune C, Rosebrock J, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Höflmayer D, Schmalfeldt B, Müller V, Wölber L, Witzel I, Paluchowski P, Wilke C, Heilenkötter U, von Leffern I, Clauditz TS, Wilczak W, Sauter G, Steurer S, Burandt E.
    Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
    Ring KL, Connor EV, Atkins KA, Ricketts W, Kashlan B, Modesitt SC.
    Int J Gynecol Cancer; 2013 Jun; 23(5):853-60. PubMed ID: 23552806
    [Abstract] [Full Text] [Related]

  • 14. Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.
    Case AS, Zighelboim I, Mutch DG, Babb SA, Schmidt AP, Whelan AJ, Thibodeau SN, Goodfellow PJ.
    Gynecol Oncol; 2008 Feb; 108(2):438-44. PubMed ID: 18022218
    [Abstract] [Full Text] [Related]

  • 15. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM.
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [Abstract] [Full Text] [Related]

  • 16. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB, Nelson GS, Ghatage P, Morris D, Duggan MA, Lee CH, Doll CM, Köbel M.
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
    Shih KK, Garg K, Levine DA, Kauff ND, Abu-Rustum NR, Soslow RA, Barakat RR.
    Gynecol Oncol; 2011 Oct; 123(1):88-94. PubMed ID: 21742371
    [Abstract] [Full Text] [Related]

  • 18. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
    Moline J, Mahdi H, Yang B, Biscotti C, Roma AA, Heald B, Rose PG, Michener C, Eng C.
    Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
    [Abstract] [Full Text] [Related]

  • 19. DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers.
    Kato M, Takano M, Miyamoto M, Sasaki N, Goto T, Tsuda H, Furuya K.
    J Gynecol Oncol; 2015 Jan; 26(1):40-5. PubMed ID: 25310854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.